In the News July 1, 2020

The Pink Sheet | US FDA Invites Warning Letter Follow-Up Inspection Alternative Proposals as Pandemic Persists

Cathy Burgess is quoted on how the U.S. Food and Drug Administration may relax its stance on re-inspection of facilities receiving Official Action Indicated notices due to the coronavirus pandemic.
Media Contact
Alex Wolfe
Communications Director

This website uses cookies to improve functionality and performance. For more information, see our Privacy Statement. Additional details for California consumers can be found here.